Sign in

CIK 0001636282

  • Large accelerated filer

Spyre Therapeutics, Inc.

Sign in to watch
Ticker
SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464312787
Phone
+1 617-651-5940
Business address
221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aeglea BioTherapeutics, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market sale 10% owner sold 19,550 shares at $10.06 ($196,673)
  3. 4 Open-market sale 10% owner sold 73,955 shares at an average $10.12 ($748,140)
  4. 4 Open-market sale 10% owner sold 42,105 shares at an average $10.06 ($423,557)
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Exercise or conversion Interim CEO acquired 15,211 shares (option exercise)
  12. 4 Open-market buy Interim CEO bought 8,288 shares at an average $4.96 ($41,078)
  13. 4 Open-market buy Chief Financial Officer and VP bought 25,959 shares at an average $4.48 ($116,223)
  14. 4 Derivatives Options or other derivatives
  15. 4 Open-market buy Director bought 17,121 shares at an average $4.86 ($83,177)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 11 of 14 · 271 filings